Zydus Life gets tentative FDA nod for empagliflozin and linagliptin tablets to treat type 2 diabetes
The combination of empagliflozin and linagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control ...
Emerging evidence suggests there may be a critical window for estrogen therapy to protect against cognitive decline later in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results